Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

TG Therapeutics Inc. sell The Goldman Sachs Group, Inc.

Start price
€18.25
24.07.23 / 50%
Target price
€14.44
24.07.24
Performance (%)
-1.86%
End price
€17.91
25.07.24
Summary
This prediction ended on 25.07.24 with a price of €17.91. With a performance of -1.86%, the SELL prediction by The_Goldman_Sachs_Gr was trending in the right direction. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
TG Therapeutics Inc. 5.649% 5.649% 93.070%
iShares Core DAX® -5.744% -6.037% 9.155%
iShares Nasdaq 100 -4.907% -12.083% 19.607%
iShares Nikkei 225® -7.230% -10.182% 3.445%
iShares S&P 500 -4.764% -6.545% 19.194%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread TG Therapeutics Inc. diskutieren
Prediction Sell
Perf. (%) -1.86%
Target price 14.437
Change
Ends at 24.07.24

TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $16.00. They now have a "sell" rating on the stock.
Ratings data for TGTX provided by MarketBeat

In the thread Trading TG Therapeutics Inc.
Prediction Sell
Perf. (%) -1.86%
Target price 14.437
Change
Ends at 24.07.24

Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten